The Indian Pharmacopoeia Commission (IPC), under the Union Health Ministry, has signed three Memoranda of Understanding (MoUs) with the Goa State Pharmacy Council (GSPC), the Quality Council of India (QCI), and HLL Infra Tech Services Limited (HITES). The move aims to reinforce pharmacovigilance, upgrade medicine quality systems, and build professional capacity across the healthcare landscape.
IPC Inks Three Pacts To Strengthen Drug Safety, Quality Benchmarks And Training
The IPC signed MoUs with GSPC, QCI, and HITES to boost pharmacovigilance and drug quality. The focus is on “empowering pharmacists” and ensuring safety through better training and ADR monitoring.
The agreement with GSPC establishes a formal structure for cooperation in adverse drug reaction monitoring, encouraging the responsible use of medicines and enhancing the skills of pharmacists in Goa.
According to an official from the Union Health Ministry, key focus areas include wider dissemination of the National Formulary of India (NFI), improving reporting under the Pharmacovigilance Programme of India (PvPI), and organizing workshops, training sessions, and continuing education modules. The initiative will also support awareness drives around drug safety, pharmacopoeial norms, and environmentally responsible practices in pharmaceutical management.
Another important component of the collaboration is strengthening ADR Monitoring Centres in the state. By improving documentation, reporting culture, and technical knowledge within hospitals and pharmacies, the partnership seeks to create a more reliable surveillance system for medicine-related risks, said the official.
Under the understanding with the Quality Council of India, the two organizations will work together on public health awareness, quality enhancement, and skill development initiatives.
The collaboration provides a broad platform for joint planning of educational campaigns, professional training, and knowledge-sharing exercises, particularly in pharmacovigilance and related domains. Both sides will pool technical expertise and institutional strengths to design programs aligned with national priorities on patient safety and standardization, said the official.
He said the framework is flexible and enables project-based cooperation, with specific assignments to be taken up through mutually agreed work plans. The larger objective is to nurture a culture of quality across the healthcare system.
Addressing the gathering on the occasion in the national capital, Joint Secretary, Union Health Ministry, Harsh Mangla, highlighted the importance of a robust regulatory architecture in delivering both primary and secondary healthcare services.
Congratulating IPC Secretary-cum-Scientific Director Dr. V. Kalaiselvan and partner organizations, he described the agreements as an important beginning. At the same time, he cautioned that such arrangements must produce tangible improvements.
MoUs, he said, should translate into measurable action rather than remain ceremonial declarations. He noted that IPC has signed several partnerships earlier as part of its sustained effort to deepen cooperation across the sector.
Advertisement
Mangla also emphasized that medicines and medical products require uncompromising attention to safety and quality. “Empowering pharmacists through structured training and continuous learning,” he added, is central to protecting patients.
He also underlined the government’s broader agenda to strengthen pharmaceuticals and healthcare delivery through supportive policies, regulatory refinement, and investment in human resources. The newly signed agreements with the three important organizations, he said, will contribute significantly to professional education and system-wide capacity building, ultimately benefiting public health.
“Drugs and pharmaceuticals deserve the highest level of attention and enhancing awareness among pharmacists is crucial for ensuring patient safety and quality healthcare delivery,” he said.
Published At: